Soluble HLA class I serum concentrations increase with transplant-related complications after liver transplantation.
Tilg
H
H
Westhoff
U
U
Vogel
W
W
Aulitzky
W E
WE
Herold
M
M
Margreiter
R
R
Huber
C
C
Grosse-Wilde
H
H
D000328:Adult; D001424:Bacterial Infections / Q000209:etiology / Q000276:immunology; D003586:Cytomegalovirus Infections / Q000209:etiology / Q000276:immunology; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006084:Graft Rejection; D006680:HLA Antigens / Q000032:analysis*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016031:Liver Transplantation / Q000009:adverse effects* / Q000276:immunology*; D008297:Male; D001613:beta 2-Microglobulin / Q000032:analysis
D006680:HLA Antigens; D007166:Immunosuppressive Agents; D001613:beta 2-Microglobulin